A team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, can decrease the amount of COVID-19 virus in the body and lower the chances of the virus coming back strongly after initial treatment. The study was published in Clinical Infectious Diseases.
Study finds metformin reduces COVID-19 viral load, viral rebound retrieved 2 May 2024 from https://medicalxpress.com/news/2024-05-metformin-covid-viral-rebound.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Nov 18, 2022Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Study finds that a dash of exercise can help students focus and enjoy university lecturesA university professor has found a way to help students—and himself—power through long lecture classes: exercise breaks.
続きを読む »
University of Glasgow study involving parrots gives new insightIf you’ve ever had to endure an automated phone line, you may have wished you could just speak to a real person. New research from the University…
続きを読む »
Study uncovers consequences of molnupiravir use to treat COVID-19A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
続きを読む »
Aging affects immune response and virus dynamics in COVID-19 patients, study findsA study examining 1031 hospitalized COVID-19 patients found that aging significantly impacts immune responses, viral dynamics, and the nasal microbiome, with older adults experiencing more severe disease symptoms and delayed viral clearance.
続きを読む »
COVID-19 Vaccination Equally Effective for Adults with Common Mental Disorders, Study FindsA new study has found that COVID-19 vaccination is equally effective for adults with common mental disorders as it is for those without. The study highlights the importance of vaccinating individuals with mental health disorders.
続きを読む »
Post-COVID not necessarily a barrier to exercise, finds studyPeople suffering from post-COVID have been discouraged from exercising because early observations suggested it could be harmful. In a study published in JAMA Network Open, researchers from Karolinska Institutet show that post-COVID does not mean that exercise must be strictly avoided.
続きを読む »